Filed: 2/14/2024ACC: 0001420506-24-000382
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 66 equity positions with a total reported market value of $147.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
66
Positions
$147.31M
Total AUM (reported)
28.21M
Total Shares
Allocation by class
COM$87.66M59.5%
COM NEW$26.76M18.2%
ALPHA ARCH 1-3$9.75M6.6%
CL A$9.46M6.4%
COM PAR $.01$3.72M2.5%
SPONSORED ADR$3.15M2.1%
COM SER A$2.53M1.7%
Portfolio Concentration
Top 3$35.86M24.3%
4–10$53.04M36.0%
11–25$46.44M31.5%
Rest$11.97M8.1%
Top 3 weight
24.3%
Top 10 weight
60.3%
Voting Authority Distribution
Total shares with voting rights: 28.21M
Sole
Full voting authority
28.21M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole66
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings66
Rows:
XENON PHARMACEUTICALS INC
SOLEShares290.54K
TypeSH
Market value$13.38M
9.08%
Sole
290.54K
Shared
0.00
None
0.00
ALIMERA SCIENCES INC
SOLEShares2.66M
TypeSH
Market value$11.49M
7.80%
Sole
2.66M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares138K
TypeSH
Market value$10.98M
7.46%
Sole
138K
Shared
0.00
None
0.00
EA SERIES TRUST
SOLEShares92.70K
TypeSH
Market value$9.75M
6.62%
Sole
92.70K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares615K
TypeSH
Market value$9.46M
6.42%
Sole
615K
Shared
0.00
None
0.00
XTANT MED HLDGS INC
SOLEShares8.03M
TypeSH
Market value$9.07M
6.16%
Sole
8.03M
Shared
0.00
None
0.00
CATALYST PHARMACEUTICALS INC
SOLEShares385K
TypeSH
Market value$6.47M
4.39%
Sole
385K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.33M
TypeSH
Market value$6.27M
4.25%
Sole
1.33M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares676K
TypeSH
Market value$6.22M
4.22%
Sole
676K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares413.61K
TypeSH
Market value$5.80M
3.94%
Sole
413.61K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares730K
TypeSH
Market value$5.61M
3.81%
Sole
730K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares71K
TypeSH
Market value$5.09M
3.45%
Sole
71K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares1.09M
TypeSH
Market value$4.95M
3.36%
Sole
1.09M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares104.91K
TypeSH
Market value$4.22M
2.87%
Sole
104.91K
Shared
0.00
None
0.00
INSMED INC
SOLEShares120K
TypeSH
Market value$3.72M
2.52%
Sole
120K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares80K
TypeSH
Market value$3.37M
2.29%
Sole
80K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares25K
TypeSH
Market value$3.15M
2.14%
Sole
25K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares111K
TypeSH
Market value$2.62M
1.78%
Sole
111K
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
SOLEShares483.18K
TypeSH
Market value$2.53M
1.72%
Sole
483.18K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares65K
TypeSH
Market value$2.31M
1.57%
Sole
65K
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares200K
TypeSH
Market value$2.17M
1.48%
Sole
200K
Shared
0.00
None
0.00
ENVVENO MEDICAL CORPORATION
SOLEShares344.47K
TypeSH
Market value$1.77M
1.20%
Sole
344.47K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares119.53K
TypeSH
Market value$1.76M
1.19%
Sole
119.53K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares20K
TypeSH
Market value$1.67M
1.13%
Sole
20K
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares78.72K
TypeSH
Market value$1.50M
1.02%
Sole
78.72K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XENON PHARMACEUTICALS INCSOLE | COM | 290.54K | SH | $13.38M 9.08% | 290.54K | 0.00 | 0.00 |
ALIMERA SCIENCES INCSOLE | COM NEW | 2.66M | SH | $11.49M 7.80% | 2.66M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 138K | SH | $10.98M 7.46% | 138K | 0.00 | 0.00 |
EA SERIES TRUSTSOLE | ALPHA ARCH 1-3 | 92.70K | SH | $9.75M 6.62% | 92.70K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 615K | SH | $9.46M 6.42% | 615K | 0.00 | 0.00 |
XTANT MED HLDGS INCSOLE | COM NEW | 8.03M | SH | $9.07M 6.16% | 8.03M | 0.00 | 0.00 |
CATALYST PHARMACEUTICALS INCSOLE | COM | 385K | SH | $6.47M 4.39% | 385K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.33M | SH | $6.27M 4.25% | 1.33M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 676K | SH | $6.22M 4.22% | 676K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 413.61K | SH | $5.80M 3.94% | 413.61K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 730K | SH | $5.61M 3.81% | 730K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 71K | SH | $5.09M 3.45% | 71K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 1.09M | SH | $4.95M 3.36% | 1.09M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 104.91K | SH | $4.22M 2.87% | 104.91K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 120K | SH | $3.72M 2.52% | 120K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 80K | SH | $3.37M 2.29% | 80K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 25K | SH | $3.15M 2.14% | 25K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 111K | SH | $2.62M 1.78% | 111K | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCSOLE | COM SER A | 483.18K | SH | $2.53M 1.72% | 483.18K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 65K | SH | $2.31M 1.57% | 65K | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 200K | SH | $2.17M 1.48% | 200K | 0.00 | 0.00 |
ENVVENO MEDICAL CORPORATIONSOLE | COM | 344.47K | SH | $1.77M 1.20% | 344.47K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 119.53K | SH | $1.76M 1.19% | 119.53K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 20K | SH | $1.67M 1.13% | 20K | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 78.72K | SH | $1.50M 1.02% | 78.72K | 0.00 | 0.00 |
Page 1 of 3